Initiate the AB-729 combination clinical trial
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Jan 2021
- Due
- 30 Jun 2021
- Checked
- 25 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Projected initiation 1H 2021”
What we found
Evidence strength A What the grades mean
The company did not initiate the AB-729 combination clinical trial by the first half of 2021, with subsequent filings indicating initiation occurred in the second half of 2021 or later.
-
A Arbutus Biopharma Corp 10-Q filed 2021-08-05
“This Phase 2a proof-of-concept clinical trial is expected to initiate in the second half of 2021.” ✓ confirmed on the page
-
A Arbutus Biopharma Corp 10-Q filed 2022-05-05
“Following FDA authorization in July 2021 to proceed with our Investigational New Drug (IND) application, we initiated AB-729-201” ✓ confirmed on the page
Market reaction: the shares moved +11.2% against the S&P 500 over the three sessions around the disclosure (4 Aug 2021 to 9 Aug 2021). What this measures
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
- Deliverable
- AB-729 combination clinical trial
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Depends on
- Partner
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Late”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Arbutus Biopharma Corp? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-ABUS-022350 · Corrections policy